Clinical Pharmacology of Lamotrigine
Doctoral thesis
Permanent lenke
http://hdl.handle.net/11250/264135Utgivelsesdato
2011Metadata
Vis full innførselSamlinger
Består av
Paper 1: Reimers, Arne. Trends and changes in the clinical use of lamotrigine. Pharmacoepidemiology and Drug Safety 2009 ;Volum 18.(2) s. 132-139 http://dx.doi.org//10.1002/pds.1690Paper 2: Reimers, Arne; Skogvoll, Eirik; Kutschera Sund, J; Spigset, Olav. Drug Interactions between Lamotrigine and Psychoactive Drugs: Evidence from a therapeutic Drug Monitoring Service. Journal of Clinical Psychopharmacology 2005 ;Volum 25.(4) s. 342-348 - Is not included due to copyright available at http://dx.doi.org//10.1097/01.jcp.0000169418.31275.a7
Paper 3: Reimers, Arne; Helde, Grethe; Brodtkorb, Eylert. Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations. Epilepsia 2005 ;Volum 46. s. 1414-1417
Paper 4: Reimers, Arne; Brodtkorb, Eylert; Helde, Grethe; Spigset, Olav. Lamotrigine Serum Concentrations Throughout the Menstrual Cycle - A Study of 2 Cases. Clinical neuropharmacology 2006 ;Volum 29.(3) s. 160-162 - Is not included due to copyright available at http://dx.doi.org//10.1097/01.WNF.0000220820.78854.3F
Paper 5: Reimers, Arne; Helde, Grethe; Bråthen, Geir; Brodtkorb, Eylert. Lamotrigine and its N2-glucuronide during pregnancy: The significance of renal clearance and estradiol. Epilepsy Research 2011 ;Volum 94.(3) s. 198-205 https://doi.org/10.1016/j.eplepsyres.2011.02.002
Paper 6: Reimers, Arne; Skogvoll, E; Sund, JK; Spigset, O. Lamotrigine in children and adolescents: the impact of age on its serum concentrations and on the extent of drug interactions. European Journal of Clinical Pharmacology 2007 ;Volum 63. s. 687-692 https://doi.org/10.1007/s00228-007-0308-2
Utgiver
Norges teknisk-naturvitenskapelige universitet, Det medisinske fakultet, Institutt for nevromedisinSerie
Doktoravhandlinger ved NTNU, 1503-8181; 2011:159Dissertations at the Faculty of Medicine, 0805-7680; 494